Target intelligence / Profile preview

Retinal cell membrane lipids

Molecular classification
Lipid, Phospholipid, Polyunsaturated fatty acid, Other
01

Overview

Retinal cell membrane lipids are essential structural and functional components of the eye, particularly within the photoreceptor outer segments. These membranes are characterized by an exceptionally high concentration of long-chain polyunsaturated fatty acids (LC-PUFAs), most notably docosahexaenoic acid (DHA), which provides the high fluidity required for the rapid signaling processes of phototransduction (SanGiovanni & Chew, 2005, Progress in Retinal and Eye Research). However, this unique lipid composition, combined with high oxygen levels and constant light exposure, makes the retina highly vulnerable to oxidative stress and lipid peroxidation (Kaur et al., 2012, Journal of Lipids). The accumulation of toxic lipid-derived byproducts, such as the bisretinoid A2E, contributes significantly to the pathogenesis of Age-related Macular Degeneration (AMD) and Stargardt disease by inducing retinal pigment epithelium (RPE) degeneration (Sparrow et al., 2012, Journal of Lipid Research). Therapeutic interventions targeting these lipids include the administration of omega-3 fatty acids to support membrane integrity and the use of antioxidants or modified retinoids, such as ALK-001, to inhibit the formation of cytotoxic lipid aggregates (Alkeus Pharmaceuticals, 2023).

Other names
Photoreceptor membrane lipidsRetinal phospholipidsRetinal polyunsaturated fatty acidsRetinal LC-PUFAs
02

Mechanism of action

Maintenance of membrane fluidity and structural integrity, reduction of oxidative stress-induced lipid peroxidation, and inhibition of the formation of toxic lipofuscin components like A2E (SanGiovanni & Chew, 2005; Sparrow et al., 2012).

03

Biological functions

Signal transductionMembrane fluidityStructural integrityPhototransduction supportOther
04

Disease associations

Neurodegenerative diseaseAge-related macular degenerationStargardt diseaseRetinitis pigmentosaDiabetic retinopathyOther
05

Safety considerations

High susceptibility of polyunsaturated fatty acids to oxidationPotential for pro-oxidant effects at excessive dosesLimited ocular bioavailability of systemic supplements
06

Interacting drugs

Docosahexaenoic acid

5 more in the full profile.

07

Biomarkers

Fundus autofluorescence (FAF) for lipofuscin monitoringMalondialdehyde (MDA) levelsA2E concentration in retinal tissuesPlasma or red blood cell omega-3 index

Beyond the preview

Go deeper on Retinal cell membrane lipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinal cell membrane lipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call